Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 8:14:1161067.
doi: 10.3389/fimmu.2023.1161067. eCollection 2023.

The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions

Affiliations
Review

The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions

Valentina Carlini et al. Front Immunol. .

Abstract

Interleukin-10 (IL-10) is a pleiotropic cytokine that has a fundamental role in modulating inflammation and in maintaining cell homeostasis. It primarily acts as an anti-inflammatory cytokine, protecting the body from an uncontrolled immune response, mostly through the Jak1/Tyk2 and STAT3 signaling pathway. On the other hand, IL-10 can also have immunostimulating functions under certain conditions. Given the pivotal role of IL-10 in immune modulation, this cytokine could have relevant implications in pathologies characterized by hyperinflammatory state, such as cancer, or infectious diseases as in the case of COVID-19 and Post-COVID-19 syndrome. Recent evidence proposed IL-10 as a predictor of severity and mortality for patients with acute or post-acute SARS-CoV-2 infection. In this context, IL-10 can act as an endogenous danger signal, released by tissues undergoing damage in an attempt to protect the organism from harmful hyperinflammation. Pharmacological strategies aimed to potentiate or restore IL-10 immunomodulatory action may represent novel promising avenues to counteract cytokine storm arising from hyperinflammation and effectively mitigate severe complications. Natural bioactive compounds, derived from terrestrial or marine photosynthetic organisms and able to increase IL-10 expression, could represent a useful prevention strategy to curb inflammation through IL-10 elevation and will be discussed here. However, the multifaceted nature of IL-10 has to be taken into account in the attempts to modulate its levels.

Keywords: COVID - 19; IL-10; Post-COVID; STAT3; alarmin; cytokine storm.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Up- and Down-regulation of IL-10, beneficial and detrimental effects.
Figure 2
Figure 2
Potential role of IL-10 in counteracting ACE2 downregulation, rebalancing RAAS system and mitigating tissue damage caused by SARS-CoV-2 in severe COVID-19 and Long COVID syndrome.
Figure 3
Figure 3
Circulating levels of IL-10 dynamically change during the clinical course of COVID-19 reflecting host immune/inflammatory state.

References

    1. Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol (2014) 5:491. doi: 10.3389/fimmu.2014.00491 - DOI - PMC - PubMed
    1. Stenken JA, Poschenrieder AJ. Bioanalytical chemistry of cytokines–a review. Anal Chim Acta (2015) 853:95–115. doi: 10.1016/j.aca.2014.10.009 - DOI - PMC - PubMed
    1. Oppenheim JJ. Cytokines: past, present, and future. Int J Hematol (2001) 74(1):3–8. doi: 10.1007/BF02982543 - DOI - PubMed
    1. Altan-Bonnet G, Mukherjee R. Cytokine-mediated communication: a quantitative appraisal of immune complexity. Nat Rev Immunol (2019) 19(4):205–17. doi: 10.1038/s41577-019-0131-x - DOI - PMC - PubMed
    1. Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling Via the Jak/Stat pathway. Protein Sci (2018) 27(12):1984–2009. doi: 10.1002/pro.3519 - DOI - PMC - PubMed

Publication types